# Talc in Treating Patients With Malignant Pleural Effusion

Source: https://onco.cc/trials/nct00002622/  
OnCo record `nct00002622` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Talc in Metastatic cancer, run by Alliance for Clinical Trials in Oncology, completed.

## Summary

Talc in Treating Patients With Malignant Pleural Effusion is a phase 3 interventional study registered as NCT00002622 by Alliance for Clinical Trials in Oncology, with 501 participants recorded, started 1994-12 and reaching its primary completion in 2005-03. Interventions recorded: talc, Talc. Conditions recorded: Metastatic Cancer.

Linked to the drug Talc because the registry names it among its interventions and Metastatic cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00002622
- Phase: 3
- Setting: Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
- Sponsor: Alliance for Clinical Trials in Oncology
- Enrolled: 501

## Sources

- ClinicalTrials.gov NCT00002622: https://clinicaltrials.gov/study/NCT00002622

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [Talc (intrapleural)](https://onco.cc/drugs/talc-sclerosant/)

---
JSON: https://onco.cc/api/v1/entities/nct00002622.json